Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19-Reference-Cited by-同舟云学术

Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19

Published:2023-09 Issue: Volume:1287 Page:135642
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Aleebrahim-Dehkordi Elahe,Ghoshouni Hamed,Koochaki Pooneh,Esmaili-Dehkordi Mohsen,Aleebrahim Elham,Chichagi Fatemeh^ORCID,Jafari Ali^ORCID,Hanaei Sara,Heidari-Soureshjani Ehsan,Rezaei Nima^ORCID

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference65 articles.

1. Clinical Manifestation and the Risk of Exposure to SARS-CoV-2 (COVID‑19);Aleebrahim-Dehkordi;Int. J. Prev. Med,2020

2. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China;Yang;medRxiv,2020

3. Receptor recognition mechanisms of coronaviruses: a decade of structural studies;Fang;J. Virol.,2015

4. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions;Li;J. Virol.,2006

5. The spike protein of SARS-CoV a target for vaccine and therapeutic development;Du;Nat. Rev. Microbiol.,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature;Microorganisms;2024-02-04

2. The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection;Nutrients;2023-08-03

3. A comprehensive Drosophila resource to identify key functional interactions between SARS-CoV-2 factors and host proteins;Cell Reports;2023-08

4. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2;Open Life Sciences;2023-01-01